FAM
MYOK

Fred Alger Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Fred Alger Management’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-8,000
Closed -$391K – 579
2018
Q4 		$391K Buy
+8,000
New +$440K ﹤0.01% 363

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fred Alger Management's MYOK Position: Q1 2019 in Review

Fred Alger Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q1 2019, closing a stake of 8,000 shares — an estimated $391K sold.

Fred Alger Management first reported a position in MYOK in Q4 2018 and held it in 1 quarter. The position peaked at $391K in Q4 2018. 168 funds tracked by Wall St. Rank hold MYOK as of Q1 2019.

  • Fred Alger Management reported no remaining MyoKardia, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Fred Alger Management sold 8,000 MyoKardia, Inc. Common Stock shares in Q1 2019, an estimated $391K.
  • Fred Alger Management first reported a position in MyoKardia, Inc. Common Stock in Q4 2018 and held it in 1 quarter.
  • Fred Alger Management's MyoKardia, Inc. Common Stock position peaked at $391K in Q4 2018.
  • 168 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q1 2019.

Based on Fred Alger Management's 13F filing for Q1 2019, filed 14 May 2019.